Your Location:
Home >
Browse articles >
Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study
RESEARCH | Updated:2026-01-27
    • Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study

    • Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study

    • 报道了癌症检测的最新进展,一项多中心研究介绍了其在人工智能辅助前列腺活检决策领域的研究进展。专家研究人员建立了GPT-4系统,该系统为中等PI-RADS评分的患者提供了解决模糊活检决策的解决方案,为医疗场景中的AI实施开辟了新的方向。
    • Military Medical Research   2025年12卷第11期 页码:1735-1746
    • DOI:10.1186/s40779-025-00621-3    

      中图分类号:
    • 收稿:2024-08-16

      录用:2025-06-12

      网络首发:2025-07-07

      纸质出版:2025-11

    Scan QR Code

  • Ming-Jun Shi, Zhi-Xiang Wang, Shuang-Kun Wang, 等. Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study[J]. Military Medical Research, 2025,12(11):1735-1746. DOI: 10.1186/s40779-025-00621-3.

    Ming-Jun Shi, Zhi-Xiang Wang, Shuang-Kun Wang, et al. Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study[J]. Military Medical Research, 2025, 12(11): 1735-1746. DOI: 10.1186/s40779-025-00621-3.

  •  
  •  

0

浏览量

1

Downloads

0

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
ADP-dependent glucokinase: the ancient, archaeal key to prostate cancer
The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
Aspartoacylase suppresses prostate cancer progres-sion by blocking LYN activation
二取二制式计算机联锁系统中的通信技术

相关作者

Jian Song
Jian Lu
Xuan Wei
Zhen-Chang Wang
Hao Zi
Meng-Yang Liu
Li-Sha Luo
Qiao Huang

相关机构

Evidence-Based Medicine Center, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine
Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University
Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University
Department of Urology, Wuhan Third Hospital, Tongren Hospital of Wuhan University
Department of Forensic Medicine, Zhongnan Hospital of Wuhan University
0